These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2469889)

  • 21. [Angiotensin-converting enzyme inhibition: side effects and risks].
    Schilling H; Scheler F
    Z Kardiol; 1988; 77 Suppl 3():47-54. PubMed ID: 2850687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
    Dahlöf B
    Blood Press Suppl; 1994; 2():35-40. PubMed ID: 8061844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibitors in the clinic: first-dose hypotension.
    Webster J
    J Hypertens Suppl; 1987 Aug; 5(3):S27-30. PubMed ID: 2822878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K; Fujii K; Kansui Y; Iida M
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.
    Zusman RM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):13-23. PubMed ID: 3037886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
    Tikkanen I; Johnston CI
    Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibitors for systemic hypertension in young and elderly patients.
    Schnaper HW
    Am J Cardiol; 1992 Apr; 69(10):54C-58C. PubMed ID: 1546640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal dosage of ACE inhibitors in older patients.
    Tomlinson B
    Drugs Aging; 1996 Oct; 9(4):262-73. PubMed ID: 8894524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitors in the elderly.
    Reid JL; Macdonald NJ; Lees KR; Elliott HL
    Am Heart J; 1989 Mar; 117(3):751-5. PubMed ID: 2645758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Converting enzyme inhibitors in the treatment of elderly hypertensives.
    Amery A; Van Hoof R; Bielen E; Fagard R; Staessen J; Thijs L; Vanhees L
    Acta Cardiol; 1989; 44(4):269-87. PubMed ID: 2552717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related issues in the treatment of hypertension.
    Black HR
    Am J Cardiol; 1993 Dec; 72(20):10H-13H. PubMed ID: 8285176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE inhibitors and pneumonia in elderly people.
    Arai T; Yasuda Y; Toshima S; Yoshimi N; Kashiki Y
    Lancet; 1998 Dec; 352(9144):1937-8. PubMed ID: 9863819
    [No Abstract]   [Full Text] [Related]  

  • 35. ACE inhibitors and reduction of the risk of pneumonia in elderly people.
    Arai T; Yasuda Y; Takaya T; Toshima S; Kashiki Y; Yoshimi N; Shibayama M; Fujiwara H
    Am J Hypertens; 2000 Sep; 13(9):1050-1. PubMed ID: 10981561
    [No Abstract]   [Full Text] [Related]  

  • 36. A case management of hypertension in the elderly in sub-Sahara Africa: lessons from Granny.
    Jingi AM; Kuate LM; Noubiap JJ
    Pan Afr Med J; 2017; 26():165. PubMed ID: 28533886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotension induced by interleukin-3 in patients on angiotensin-converting enzyme inhibitors.
    Dercksen MW; Hoekman K; Visser JJ; ten Bokkel Huinink WW; Pinedo HM; Wagstaff J
    Lancet; 1995 Feb; 345(8947):448. PubMed ID: 7853962
    [No Abstract]   [Full Text] [Related]  

  • 38. The aging process: implications for ACE inhibition. Proceedings of a symposium. Montreux, March 31, 1987.
    Gerontology; 1987; 33 Suppl 1():1-56. PubMed ID: 3440522
    [No Abstract]   [Full Text] [Related]  

  • 39. Medicine in the elderly.
    Diggory P; Homer A; Liddle J; Pratt CF; Samadian S; Tozer R; Weinstein C
    Postgrad Med J; 1991 May; 67(787):423-45. PubMed ID: 1852662
    [No Abstract]   [Full Text] [Related]  

  • 40. Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide.
    Neldam S; Forsén B;
    Drugs Aging; 2001; 18(3):225-32. PubMed ID: 11302289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.